Diabetes Clinical Trials in Florida

Showing 381-394 of 394 trials

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

NCT00482950

This study is to test the efficacy and safety of PHX1149T in combination with metformin, a glitazone, or metformin and a glitazone in subjects with Type 2 diabetes for 12 weeks. After completing the 12 week double blind part of the study, subjects can enter an open label extension study

Type 2 Diabetes Mellitus

Phenomix400 participantsStarted Apr 2007

Chula Vista, California, United States • Fullerton, California, United States • Long Beach, California, United States +23 more locations

COMPLETEDPhase 241 miles

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

NCT00065312

The purpose of this study is to determine if an investigational drug is safe and efficacious for poorly controlled type 2 diabetes mellitus.

Diabetes Mellitus, Non-Insulin-Dependent

Eli Lilly and Company

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Peoria, Arizona, United States +39 more locations

PreviousPage 20 of 20

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Diabetes Trials in Other Cities

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes

Obese Patients With Type 2 Diabetes

Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women

Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

GALLANT 4 Tesaglitazar vs. Glibenclamide

Other Conditions in Florida